Get startedLog in
    Picture of Initiator Pharma A/S logo

    INIT — Initiator Pharma A/S News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Initiator Pharma Gets CTA Approval For IPTN2021 Program Phase I Study

    Picture of Initiator Pharma A/S logoInitiator Pharma A/S
    25/11/2021 08:38
    Nov 25 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * INITIATOR PHARMA RECEIVES CTA APPROVAL FOR IPTN2021
PROGRAM
PHASE I STUDY TO ASSESS PAIN REDUCING EFFECTS
    * SUBJECT INCLUSION AND DOSING IS EXPECTED TO COMMENCE IN
JANUARY
2022

Source text for Eikon:  ID:nMFN9BW7JV 
Further company coverage:  INIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

    Recent news on Initiator Pharma A/S

    See all news